Announced Wed, 6 May · 14:59 IST

The Company has fixed Friday, 28th August, 2026, as the Record date for the Payment of Dividend for the Financial Year 2025-26 as well as cut-off date for Remote e-voting and e-voting during ....

Corporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹1079.90
prior close
₹1148.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.8+0.8+0.4+8.3+7.8+6.4+7.1+9.0+11.1+6.9+7.4+2.0
Up moveDown movePending
AI summary

Jenburkt Pharmaceuticals Ltd has fixed Friday, 28th August 2026, as the record date for determining shareholder eligibility for dividend payment related to Financial Year 2025-26. The dividend will be proposed for declaration at the company's 41st Annual General Meeting scheduled on 4th September 2026, and will be paid within 30 days of the AGM. The same date (28th August 2026) has also been set as the cut-off date for remote e-voting and e-voting during the AGM. This is a routine corporate action filing under SEBI Listing Regulation 42(1)(a).

Likely market impact

Shareholders must be listed in the register of members by 28th August 2026 to be eligible for the dividend. The dividend amount has not been specified in this filing and will be disclosed at the AGM.